Product Information
QUININE SULFATE 324 MG CAPSULE is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $0.6980 per EA under NDC 50742023830. Its NADAC has been published 456 times since Jan 10, 2018.
FDA first approved this application on Jul 22, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
324 mg/1
Manufacturer
Ingenus Pharmaceuticals LLCNDC
50742023830
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
QUININE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA204372FDA Approved
7/22/2015
TE Code
AB
On Market Since
12/11/2017
Pharmacological Classes
Price Statistics
The NADAC for QUININE SULFATE 324 MG CAPSULE has been published 456 times since Jan 10, 2018, and over the history we have for it it has declined 77.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6980 per EA |
|---|---|
| All-time high | $3.2316 (Mar 14, 2018) |
| All-time low | $0.6067 (Jan 17, 2024) |
| 52-week high | $0.7882 |
| 52-week low | $0.6367 |
| Median price | $1.3660 |
| Average price | $1.3872 |
| Largest weekly change | +52.1% (Mar 20, 2024) |
| Weeks tracked | 456 |
| Tracking since | Jan 10, 2018 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ingenus Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
QUININE SULFATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antimalarial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of QUININE SULFATE 324 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for QUININE SULFATE 324 MG CAPSULE, manufactured by Ingenus Pharmaceuticals LLC, is $0.6980 per EA (NDC 50742023830), effective Sep 30, 2026.
How has the price of QUININE SULFATE 324 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for QUININE SULFATE 324 MG CAPSULE has declined 77.3%. It has been tracked across 456 weekly CMS publications since Jan 10, 2018.
What are the highest and lowest recorded NADAC prices for QUININE SULFATE 324 MG CAPSULE?
Since Jan 10, 2018, the NADAC for QUININE SULFATE 324 MG CAPSULE has ranged from a low of $0.6067 (Jan 17, 2024) to a high of $3.2316 (Mar 14, 2018), with a median of $1.3660 per EA.
Are there cheaper alternatives to QUININE SULFATE 324 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as QUININE SULFATE 324 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures QUININE SULFATE 324 MG CAPSULE?
QUININE SULFATE 324 MG CAPSULE (NDC 50742023830) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.